首页>Clinical lymphoma, myeloma & leukemia>Cardiac, Vascular and Hypertension Safety of Bosutinib vs Imatinib for Newly Diagnosed Chronic Myeloid Leukemia in the BFORE Trial
Cardiac, Vascular and Hypertension Safety of Bosutinib vs Imatinib for Newly Diagnosed Chronic Myeloid Leukemia in the BFORE Trial
作者单位：Pfizer Inc, Cambridge, MA USA[1]Royal Liverpool Univ Hosp, Liverpool, Merseyside, England[2]Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA[3]Univ Milano Bicocca, Monza, Italy[4]Augusta Univ, Georgia Canc Ctr, Augusta, GA USA[5]Univ Klinikum RWTH Aachen, Aachen, Germany[6]Pfizer SLU, Madrid, Spain[7]Univ Utah, Salt Lake City, UT USA[8]
换一批
换一批
